Oral glucose ingestion stimulates cholecystokinin release in normal subjects and patients with non-insulin-dependent diabetes mellitus

Elrick, 1964, Plasma insulin response to oral and intravenous glucose administration, J Clin Endocrinol Metab, 24, 1076, 10.1210/jcem-24-10-1076 McIntyre, 1964, New interpretation of oral glucose tolerance, Lancet, 2, 20, 10.1016/S0140-6736(64)90011-X Unger, 1969, Entero-insular axis, Arch Intern Med, 123, 261, 10.1001/archinte.123.3.261 Creutzfeldt, 1985, New development in the incretin concept, Diabetologia, 28, 565, 10.1007/BF00281990 Nauck, 1989, Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: Interactions with glucose, phenylalanine, and cholecystokinin-8, J Clin Endocrinol Metab, 69, 654, 10.1210/jcem-69-3-654 Ahren, 1991, Effect of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man, Diabetes Res Clin Pract, 13, 153, 10.1016/0168-8227(91)90059-M Okabayashi, 1989, Cholecystokinin in the entero-insular axis, Diabetes Res Clin Pract, 7, S79, 10.1016/0168-8227(89)90092-2 Rushakoff, 1990, The role of cholecystokinin and other gut peptides on regulation of postprandial glucose and insulin levels, vol 92, 125 Liddle, 1985, Cholecystokinin bioactivity in human plasma, 75, 1144 Liddle, 1988, Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans, J Clin Invest, 81, 1675, 10.1172/JCI113505 Koide, 1993, Role of endogenous bile on basal and postprandial CCK release in humans, Dig Dis Sci, 38, 1289, 10.1007/BF01296080 Liddle, 1986, Regulation of gastric emptying in humans by cholecystokinin, J Clin Invest, 77, 992, 10.1172/JCI112401 Meyer, 1989, Role of cholecystokinin in regulation of gastrointestinal motor functions, Lancet, 2, 12, 10.1016/S0140-6736(89)90255-9 Hildebrand, 1990, Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man, J Clin Invest, 85, 640, 10.1172/JCI114486 Schmidt, 1991, Role of CCK in regulation of pancreaticobiliary function and GI motility in humans: Effects of loxiglumide, Am J Physiol, 260, G197 Otsuki, 1979, Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas, J Clin Invest, 63, 478, 10.1172/JCI109325 Hermansen, 1984, Effects of cholecystokinin (CCK)-4, nonsulfated CCK-8, and sulfated CCK-8 on pancreatic somatostatin, insulin, and glucagon secretion in the dog: Studies in vitro, Endocrinology, 114, 1770, 10.1210/endo-114-5-1770 Verspohl, 1986, Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans, Diabetes, 35, 38, 10.2337/diabetes.35.1.38 Rossetti, 1987, Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats, 36, 1212 Sakamoto, 1985, Localization of saturable CCK binding sites in rat pancreatic islet by light and electron microscopic autoradiography, Diabetes, 34, 390, 10.2337/diabetes.34.4.390 Okabayashi, 1990, Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas, Pancreas, 5, 291, 10.1097/00006676-199005000-00008 Karlsson, 1992, CCK-8-stimulated insulin secretion in vivo is mediated by CCKA receptors, Eur J Pharmacol, 213, 145, 10.1016/0014-2999(92)90245-Y Otsuki, 1989, Bioassay of plasma cholecystokinin in rat and human: Inhibition of protein synthesis prevents the decrease in the sensitivity and responsiveness of isolated rat pancreatic acini to CCK-8, Pancreas, 4, 447, 10.1097/00006676-198908000-00009 Tachibana, 1995, Effects of tetraprenylacetone on pancreatic exocrine secretion and acute pancreatitis in two experimental models in rats, Int J Pancreatol, 17, 147 Christ, 1969, Investigations of absorption, excretion and metabolism in man after administration of 14C-labelled HB 419, Horm Metab Res, 1, 51 Otsuki, 1989, Loxiglumide: A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas, Dig Dis Sci, 34, 857, 10.1007/BF01540270 Hashimura, 1982, Production of rabbit antibody specific for amino-terminal residues of cholecystokinin octapeptide by selective suppression of cross reactive antibody response, J Immunol Methods, 55, 375, 10.1016/0022-1759(82)90097-7 Kanayama, 1987, Plasma cholecystokinin-octapeptide like immunoreactivity in patients with hepatic cirrhosis, Life Sci, 41, 1915, 10.1016/0024-3205(87)90743-0 Ceska, 1969, A new and rapid method for the clinical determination of α-amylase activities in human serum and urine, Clin Chim Acta, 26, 437, 10.1016/0009-8981(69)90071-0 Bondar, 1974, Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum, Clin Chem, 20, 586, 10.1093/clinchem/20.5.586 Morgan, 1963, Immunoassay of insulin: Two antibody system, Diabetes, 12, 115, 10.2337/diab.12.2.115 Stern, 1973, Gastrin release in postprandial ulcer patients: Evidence of release of duodenal gastrin, Gastroenterology, 64, 363, 10.1016/S0016-5085(73)80157-X Jorde, 1987, The insulinotropic effect of gastric inhibitory polypeptide in non-insulin dependent diabetes, Ital J Gastroenterol, 19, 76 Kreymann, 1987, Glucagon-like peptide 1 7–36: A physiological incretin in man, Lancet, 2, 1300, 10.1016/S0140-6736(87)91194-9 Orskov, 1993, Biological effects and metabolic rates of glucagon-like peptide-17–36 amide and glucagon-like peptide-1 7–37 in healthy subjects are indistinguishable, Diabetes, 42, 658, 10.2337/diabetes.42.5.658 Rushakoff, 1987, Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans, J Clin Endocrinol Metab, 65, 395, 10.1210/jcem-65-3-395 Reimers, 1988, Lack of insulinotropic effect of endogenous and exogenous cholecystokinin in man, Diabetologia, 31, 271 Schmid, 1989, Effect of CCK on insulin, glucagon, and pancreatic polypeptide levels in humans, Pancreas, 4, 653, 10.1097/00006676-198912000-00001 Fried, 1991, Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man, 34, 721 Meerof, 1975, Control of gastric emptying by duodenal contents in man, Gastroenterology, 68, 1144, 10.1016/S0016-5085(75)80228-9 Owyang, 1986, Trypsin suppression of pancreatic enzyme secretion, 91, 637 Hildebrand, 1991, Effect of cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans, J Clin Endocrinol Metab, 72, 1123, 10.1210/jcem-72-5-1123 Liddle, 1990, Regulation of pancreatic endocrine function by cholecystokinin: Studies with MK-329, a nonpeptide cholecystokinin receptor antagonist, J Clin Endocrinol Metab, 70, 1312, 10.1210/jcem-70-5-1312 Zawalich, 1987, Prior cholecystokinin exposure sensitizes islets of Langerhans to glucose stimulation, Diabetes, 36, 118, 10.2337/diabetes.36.1.118 Fehmann, 1991, Priming effect of glucagon-like peptide-1 (7–36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas, Biochim Biophys Acta, 1091, 356, 10.1016/0167-4889(91)90200-H Nakano, 1986, High plasma cholecystokinin response following ingestion of test meal by patients with non-insulin dependent diabetes mellitus, Regul Pept, 14, 229, 10.1016/0167-0115(86)90005-4 Khalil, 1985, Effect of aging on gallbladder contraction and release of cholecystokinin-33 in humans, Surgery, 98, 423